NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Unless nwbo's tech has value, an acquirer would not be able to use most of the tax loss carryforward.

This is an interesting angle. Just how would a company demonstrate that NWBO’s technology has value, let’s say in an ambiguous TLD result that, theoretically, a deep-pocketed investor might want to pursue through a better designed trial? This seems like a case in which the technology has unrealized value.

Would it be possible to pursue and demonstrate that technology value in such a way as not to run afoul of the IRS and yet milk the tax loss carryforward in a way that they come out significantly ahead?